Gerald Ostrov Net Worth

The estimated Net Worth of Gerald M Ostrov is at least $17.8 Thousand dollars as of 13 January 2022. Mr. Ostrov owns over 10,000 units of Entera Bio Ltd stock worth over $17,800 and over the last 13 years he sold ENTX stock worth over $0. In addition, he makes $0 as Independent Director at Entera Bio Ltd.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Ostrov ENTX stock SEC Form 4 insiders trading

Gerald has made over 1 trades of the Entera Bio Ltd stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of ENTX stock worth $27,400 on 13 January 2022.

The largest trade he's ever made was buying 10,000 units of Entera Bio Ltd stock on 13 January 2022 worth over $27,400. On average, Gerald trades about 667 units every 0 days since 2011. As of 13 January 2022 he still owns at least 10,000 units of Entera Bio Ltd stock.

You can see the complete history of Mr. Ostrov stock trades at the bottom of the page.

Gerald Ostrov biography

Gerald M. Ostrov serves as Independent Director of the Company. Mr. Ostrov consults and invests in new technologies in the medical device and consumer products fields. Mr. Ostrov currently serves on the board of directors of several privately held companies, including Mother’s Choice, a natural products company working with industry giants, Addon Optics, an innovative technology company, and Nuvo, a developer of next generation baby and mother health monitoring for both hospital and home use. From 2008 to 2010, he served as Chairman and CEO of Bausch & Lomb. There Mr. Ostrov led the stabilization, streamlining and pipeline building of Bausch & Lomb following its going-private transaction. From 1998 until 2006, Mr. Ostrov very successfully served as Company Group Chairman for Johnson & Johnson’s Worldwide Vision Care businesses. From 1991 to 1998, Mr. Ostrov worked for Johnson & Johnson and quickly rose to serve as Company Group Chairman of the Consumer and Personal Care businesses in North America. From 1982 to 1991, he served as President of CIBA Consumer Pharmaceuticals Company. From 1976 to 1982, he worked for the Health Care Division of Johnson & Johnson. From 1973 to 1976, Mr. Ostrov worked at Procter & Gamble. Mr. Ostrov holds a B.S. from Cornell and an M.B.A. from Harvard.

How old is Gerald Ostrov?

Gerald Ostrov is 70, he's been the Independent Director of Entera Bio Ltd since 2019. There are 1 older and 16 younger executives at Entera Bio Ltd. The oldest executive at Entera Bio Ltd is Gerald Lieberman, 73, who is the Independent Chairman of the Board.

What's Gerald Ostrov's mailing address?

Gerald's mailing address filed with the SEC is KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR, JERUSALEM, L3, 9112002.

Insiders trading at Entera Bio Ltd

Over the last 3 years, insiders at Entera Bio Ltd have traded over $0 worth of Entera Bio Ltd stock and bought 467,822 units worth $484,536 . The most active insiders traders include Gerald M Lieberman, Miranda Jayne Toledano, and Sean Ellis. On average, Entera Bio Ltd executives and independent directors trade stock every 32 days with the average trade being worth of $36,205. The most recent stock trade was executed by Haya Taitel on 12 January 2024, trading 9,500 units of ENTX stock currently worth $9,405.

What does Entera Bio Ltd do?

entera bio ltd. is a biotechnology company located in israel.

Complete history of Mr. Ostrov stock trades at Oramed Pharmaceuticals, Inc, Orasure Technologies, and Entera Bio Ltd

Entera Bio Ltd executives and stock owners

Entera Bio Ltd executives and other stock owners filed with the SEC include:

• Phillip Schwartz,
  President of Research and Development
• Gerald Lieberman,
  Independent Chairman of the Board
• Arthur Santora,
  Chief Medical Officer
• Dr. Phillip Schwartz Ph.D.,
  Exec. VP, Pres of R&D and Director
• Roger Garceau,
  Chief Executive Officer, Director
• Hillel Galitzer,
  Chief Operating Officer
• Dr. Hillel Galitzer,
  Chief Operating Officer
• Dr. Arthur C. Santora II, M.D., Ph.D.,
  Chief Medical Officer
• Kiryat Hadassah,
  IR Contact Officer
• Miranda Toledano,
  Independent Director
• Gerald Ostrov,
  Independent Director
• Faith Charles,
  Independent Director
• Yonatan Malca,
  Director
• Sean Ellis,
  Director
• Zeev Bronfeld,
  Director
• Jonathan Lieber,
  Chief Financial Officer - U.S.-based
• Dana Yaacov-Garbeli,
  Chief Financial Officer
• Dr. Roger J. Garceau,
  Chief Devel. Advisor & Director
• Ramesh Ratan,
  U.S. Chief Financial Officer
• Dana Yaacov-Garbeli CPA,
  Chief Financial Officer
• Dr. Spiros Jamas,
  CEO & Director
• Haya Taitel,
  Director
• Ramesh Ratan,
  U.S.based CFO
• Spiros Jamas,
  Chief Executive Officer
• Ron Mayron,
  Director